Newborns and GERD

The research has shown that histamine 2 receptor antagonists or H2RAs as well as the proton pump inhibitors or PPIs are usually prescribed to preterm neonates as well as those with congenital anomalies, even if there is a growing debate about its safety to the babies. There are some results from the reflective study that was published in a pedia journal online.  The prescription of the acid suppressing drugs like the H2RAs as well as the PPIs for neonates has become massive in the past years. On the other hand, some newborn studies and researchers have not shown any improvement in terms of the GERD that shares the signs after the treatment have been given with the 2 pills and the safety and efficiency of the stress ulcer propylaxis with the 2 pills have been doubtful.

The use of these pills in newborn babies has been associated with infections, NEC and the risks of mortality. At the moment, there is not resulted based data yet about the oral or the definite therapy for the newborns or the studies on the duration of the pills use as well as the risks involves among the newborns in the Neonatal ICU units.  The study made by the authors of a children’s hospital made an analysis to know the rampancy of the treatment as well as the duration of the pills used among newborns in the hospital throughout America and to know the diagnosis as well as the demographic factors linked with the use.

Pedia Health Information Systems Database

They have assessed the conditions of the one hundred twenty-two babies who were admitted from January of 2006 as well as those who were admitted in March of 2013 throughout the hospitals in the Pedia Health Information Systems Database. They have computed that the adjusted possibility of the babies being given with the pills linked to the diagnosis, pregnancy and gender. Among the babies who went through the study, 23% of them got both of the pills; particularly the 19% got the H2RAs while the 10% got the PPIs. The populace most likely to get the H2RA as well as the PPI treatment at the same time was greatly preterm as well as term infants.

Those with GERD had the highest amount of H2RA and PPI treatment possibility risk that will be followed by a congenital heart disease, while the others were diagnosed with ENT infections. On the other hand, while the time period is ongoing, the percentage of the babies treated with the said agents never went down, with the H2RA use going down from 2006- 2013 as well as the PPI using the declining after the 2010. It is persuaded that the doctors are starting to focus much on the warnings and they lessen the use of the said pills.